- Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. de Werf, Frans Van; Arnold, Alfred E.R. // BMJ: British Medical Journal (International Edition);11/26/88, Vol. 297 Issue 6660, p1374
Assesses the effect of intravenous recombinant tissue type plasminogen activator on the size of infarct, left ventricular function, and survival in acute myocardial infarction. Rate of ejection fraction after intravenous streptokinase; Limitation of expansion of the infarct and cardiac...
- Why do MI patients delay calling? Pinkowish, Mary Desmond // Patient Care;5/30/1995, Vol. 29 Issue 10, p88
Presents an excerpt from an article by Meischke et al on attitudes of acute myocardial infarction (AMI) patients published in the periodical `Annual of Emergency Medicine.' Practice of AMI patients of waiting six hours before seeking help; Need for more education on AMI symptoms.
- Role of patients' view of their illness in predicting return to work and functioning after... Petrie, Keith J.; Weinman, John // BMJ: British Medical Journal (International Edition);5/11/96, Vol. 312 Issue 7040, p1191
Presents information on a study on the influence of patients' attitude to their myocardial infarction illness on return to work decisions. Category of illness perceptions; Importance of personal models of illness to recovery after myocardial infarction; Measurement of anxiety and psychological...
- Why MI patients wait to dial 911: Confusion over symptoms. // Geriatrics;May95, Vol. 50 Issue 5, p66
Presents an abstract of the article `Reasons patients with chest pain delay or do not call 911,' by H. Meischke, M.T. Ho et al originally published in the `Annals of Emergency Medicine' journal.
- Holding GUSTO Up to the Light. Lee, Kerry L.; Califf, Robert M.; Simes, John; Van de Werf, Frans; Topol, Eric J. // Annals of Internal Medicine;5/15/94, Vol. 120 Issue 10, p876
Provides information on the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries trial. Consistency of results among subgroups; Magnitude of the treatment difference.
- A Response to 'Holding GUSTO Up to the Light' Ridker, Paul M.; O'Donnell, Christopher J.; Marder, Victor J.; Hennekens, Charles H. // Annals of Internal Medicine;5/15/94, Vol. 120 Issue 10, p882
Discusses the alternative interpretations of the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occuluded Coronary Arteries (GUSTO) findings. Prespecified subgroup analysis; Open-label design of GUSTO.
- T-PA beats streptokinase in latest battle. Hurley, Mary Lou // RN;Sep93, Vol. 56 Issue 9, p92
Reports on the effectivity of tissue plasminogen activator altephase (Activase) in treating patients after a myocardial infarction than treatment with streptokinase (Kabikinase, Streptase). Results of study conducted on patients given the drugs; Mortality rate after 30 days; Incidence of stroke.
- Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction. Schömig, Albert; Kastrati, Adnan; Dirschinger, Josef; Mehilli, Julinda; Schricke, Ullrich; Pache, Jürgen; Martinoff, Stefan; Neumann, Franz-Josef; Schwaiger, Markus // New England Journal of Medicine;08/10/2000, Vol. 343 Issue 6, p385
Background: Prevention of myocardial damage is the main goal of all reperfusion therapies in patients with acute myocardial infarction. The relative efficacy of various reperfusion strategies is under intensive investigation. We assessed whether coronary stenting combined with the blockade of...
- ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised... Baigent, Colin; Collins, Rory; Appleby, Paul; Parish, Sarah; Sleight, Peter; Peto, Richard // BMJ: British Medical Journal (International Edition);05/02/98, Vol. 316 Issue 7141, p1337
Presents a study which looks at the effects of intravenous streptokinase and oral aspirin, on survival in patients with suspected acute myocardial infarction. Detailed information on patients and methodologies used in the study; Results of the study; Discussion on the study.